When Anthony Rendon signed a seven-year, $245 million deal with the Los Angeles Angels in December 2019, he was coming off a World Series title with the Washington Nationals. The plan was simple: pair him with Mike Trout and Shohei Ohtani, and suddenly Anaheim had one of the most dangerous lineups in baseball. The theory was perfect. The reality was something else entirely.
The Numbers Tell the Story
In nearly six seasons with the Angels, Rendon appeared in just 257 of a possible 1,032 games — 25%. His slash line over that stretch: .242/.348/.369, with only 22 home runs across 1,095 plate appearances. For a player brought in to anchor a lineup, those numbers represent one of the most painful contracts in recent MLB history.
The culprit was injuries — back, hip, wrist, shoulder. None of them catastrophic on their own, but together they turned one of the best hitters of the previous decade into a ghost in the Angels dugout. The team kept paying. Rendon kept missing time. And the cycle never broke.
A Deferral as the Only Way Out
By mid-December 2025, both sides had accepted the uncomfortable truth: this wasn’t going to work. The Angels couldn’t justify carrying $38 million more in payroll for a player who couldn’t take the field. Rendon, for his part, had a body that simply wouldn’t cooperate.
The solution was a deferral — spreading those remaining $38 million over three to five seasons. It’s not a clean break. It’s paying off a failure in installments. But it gave both sides room to breathe and move forward.
Agent Scott Boras negotiated one meaningful upside for his client: Rendon is no longer tied to the Angels, which means he’s free to attempt a comeback elsewhere if his health allows. A small detail, but not an insignificant one.
Why This Story Still Matters
The Rendon contract isn’t just a bad-luck story — it’s a case study in how the free-agent market operates on two tracks: promise and reality. Teams sign players based on recent performance, age, and projected durability. Rendon had been an offensive machine in Washington. But baseball offers no durability guarantees, and the human body doesn’t care how many millions are attached to it.
For the Angels, the financial weight of this deal crowded out other moves year after year. While the money kept flowing out, the roster stagnated. The December 2025 deferral is the modern way of closing that kind of wound — not a cure, but at least a path forward.
For front offices around the league, the Rendon deal will be referenced for years. Not as an argument against paying players, but as a reminder of why contract structure — length, opt-outs, injury protections — matters just as much as the dollar figure at the top.
- Contract: 7 years, $245 million (signed December 2019)
- Games played: 257 of 1,032 possible (25%)
- Slash line: .242/.348/.369, 22 HR in 1,095 PA
- Remaining money deferred: $38 million, spread over 3–5 seasons
- Status: Free to sign elsewhere; will not return to the Angels
